Table 2. Logistic regression of MATN3 expression^# and clinical pathological characteristics.

Clinical characteristics	Total (N)	OR	95% CI	P value
Age at diagnosis (y)
50–59 vs. <49	112	0.941	0.386–2.269	0.892
60–69 vs. <49	135	0.906	0.379–2.137	0.821
70–79 vs. <49	147	0.789	0.333–1.847	0.585
>80 vs. <49	55	0.605	0.204–1.751	0.356
Stage classification
II vs. I	164	2.679	1.363–5.426	0.005*
III vs. I	203	2.233	1.169–4.402	0.017*
IV vs. I	91	2.353	1.004–5.634	0.017*
Tumor (T) classification
T2 vs. T1	99	4.363	1.325–19.820	0.027*
T3 vs. T1	186	6.154	1.960–27.163	0.005*
T4 vs. T1	117	6.261	1.937–28.133	0.005*
Node (N) classification
N1 vs. N0	207	0.982	0.568–1.696	0.948
N2 vs. N0	185	1.297	0.721–2.340	0.386
N3 vs. N0	184	1.41	0.782–2.556	0.255
Metastasis (M) classification
M1 vs. M0	355	0.776	0.335–1.756	0.554
Grade (G) classification
G2 vs. G1	145	1.522	0.416–6.177	0.529
G3 vs. G1	228	1.514	0.421–6.059	0.53
Gender
Male vs. female	375	1.088	0.713–1.662	0.695

^#, categorical dependent variable, greater or less than the median expression level; *, P<0.05. MATN3, matrilin-3.